| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |